Navigation Links
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Date:8/21/2007

available at http://www.lilly.com.

P-LLY

This press release contains forward-looking statements about the potential of Cymbalta for the treatment of fibromyalgia, and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that the product will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

(1) Ahles TA, et al. "Psychiatric status of patients with primary

fibromyalgia, patients with rheumatoid arthritis, and subjects without

pain: a blind comparison of DSM-III diagnoses." American Journal of

Psychiatry 1991; 148:1721-1726.

(2) Arnold LM, et al. "Comorbidity of fibromyalgia and psychiatric

disorders." Journal of Clinical Psychiatry 2006; 67:1219-1225.

(3) American College of Rheumatology Web site -

http://www.rheumatology.org/public/factsheets/fibromya_new.asp;

visited Aug. 3, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
9. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
10. Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
11. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  The U.S. ... AirStrip® Sense4Baby™ wireless maternal/fetal monitoring ... U.S. by pregnant patients to self-administer non-stress tests ... from the FDA for use accompanied by medical ... the European Commission in 2013 for self-administration, including ...
(Date:4/1/2015)...  Egalet Corporation (Nasdaq: EGLT ) ("Egalet"), ... developing, manufacturing and marketing innovative pain treatments, today ... million aggregate principal amount of its convertible senior ... placement to qualified institutional buyers pursuant to Rule ... amended (the "Act"). Egalet also granted the initial ...
(Date:4/1/2015)... 1, 2015   Advocates for Responsible Care , ... health care professionals, patient advocates and human rights specialists, ... will go live at 9:00 a.m. today. ... Reach is a new campaign to limit rising out-of-pocket ... by Advocates for Responsible Care, in partnership with the ...
Breaking Medicine Technology:AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 3AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7'Rx in Reach' Campaign Launches in Georgia 2'Rx in Reach' Campaign Launches in Georgia 3
... 6, 2012  Mylan Inc. (Nasdaq: MYL ) ... of two dermatological products from Valeant Pharmaceuticals. Mylan has ... Phosphate / Benzoyl Peroxide Gel, which is the generic ... manufactured and marketed the generic version of this product ...
... welcomes Michael Podany as Vice President of Sales, West USA ... Mr. Podany will be responsible for developing and managing sales ... Keith (GM, Director of Sales, USA). Mr. ... in creating, managing, and growing a new base of business ...
Cached Medicine Technology:Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant 2Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant 3Samsung Medison America Appoints Michael Podany as Vice President of Sales, West USA 2
(Date:4/1/2015)... (PRWEB) April 01, 2015 The panel ... and telematics service providers to build a program that ... and complicated legal implications further down the line. This ... wake of the news that OBD-II port dongles aren’t ... In January, it was reported that Progressive’s Snapshot ...
(Date:4/1/2015)... 01, 2015 Taking an important step ... League for Nursing Commission for Nursing Education Accreditation (NLN ... the first NLN CNEA Board of Commissioners. Working with ... the 15-member board will provide leadership and direction to ... accreditation decisions for nursing programs that seek accreditation from ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 EAGAN, Minn. ... Minnesota and its family of companies (Blue Cross) today ... out the year with net income of $61.5 million, ... losses. The organization reported a net operating loss of ... a negative operating margin of one-tenth of one percent ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 GrassrootsHealth, ... announcing two continuing medical education (CME) courses about ... help practitioners become more confident in measuring, prescribing, ... After completion of these CME courses, practitioners can ... The CME courses available are “Vitamin D, Sunshine, ...
(Date:4/1/2015)... 01, 2015 Aging2.0 , the ... announces the launch of the Aging2.0 Alliance ... stakeholders and technology companies. The announcement was made today ... and Business Strategies Forum in San Diego, CA. ... Alliance program is now open for additional members. “This ...
Breaking Medicine News(10 mins):Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 3Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4
... Inc. (Nasdaq: SLTM ), a global leader ... has received regulatory clearance to market and sell Thermage(R) ... opportunity to market the premier non-invasive procedure for tightening ... said Stephen J. Fanning, Chairman of the Board, President ...
... Cites Frequent Hand Washing as Key PrecautionNEW YORK, April ... around the world are taking proactive steps to protect ... over-the-counter flu medication can help you avoid this disease, ... recommending a simpler measure: frequent, thorough hand washing. With ...
... NORCROSS, Ga., April 30 Immucor, Inc. (Nasdaq: ... instrument-reagent systems to the blood transfusion industry, today announced ... America and Merrill Lynch 2009 Health Care Conference in ... simultaneous webcast. The Company,s presentation is scheduled for ...
... figures are in US dollars), - ... - Product sales revenue increases 173%,VANCOUVER, ... today that it recorded revenues of $6,655,342 for the ... ended December 31, 2007. Clinic operations revenue increased 100% ...
... channel blocker, angiotensin receptor blocker and diuretic (amlodipine, ... clinical trial, Exforge HCT demonstrated significantly greater reductions ... dual combinations of its components - Up to ... help control their blood pressure and many need ...
... China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin ... pharmaceutical products in China, today announced that it ... investor communications best-practices in the U.S. capital markets.Ms. ... stated, "Our decision to hire ICR is part ...
Cached Medicine News:Health News:Solta Medical Receives Regulatory Approval to Market Thermage Systems in China 2Health News:Photos: How You Can Help Protect Yourself & Your Family From Swine Flu (H1N1) 2Health News:Photos: How You Can Help Protect Yourself & Your Family From Swine Flu (H1N1) 3Health News:CRH Medical reports year end results 2Health News:CRH Medical reports year end results 3Health News:Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill 2Health News:Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill 3Health News:Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill 4Health News:Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill 5Health News:Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill 6Health News:Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill 7Health News:China Pharma Holdings, Inc. Retains Global Investor Communications Team 2
... Revo Suture Anchor offers a simple and ... rotator cuff repair. The cutting tip requires ... with two #2 strands of braided polyester ... are avoided with the Independent Suture Sliding ...
The Atakr II RF Generator provides high power output with the integral safety of closed-loop temperature control using the embedded thermocouples in Medtronic RF ablation catheters....
... dedicated electrophysiology system on the market today, ... Fischer's patented "C inside a C" design ... the ultimate in patient access and flexibility. ... EPX2 minimizes equipment footprint and can be ...
... The requirements for Bi-Plane Electrophysiology imaging ... to decrease procedure time and reduce radiation ... become paramount in deciding between Single and ... goal of maintaining its leadership position in ...
Medicine Products: